PortfoliosLab logo
FAT vs. FGEN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between FAT and FGEN is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

FAT vs. FGEN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in FAT Brands Inc. (FAT) and FibroGen, Inc. (FGEN). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

FAT:

68.00%

FGEN:

139.02%

Max Drawdown

FAT:

-4.51%

FGEN:

-8.46%

Current Drawdown

FAT:

-4.51%

FGEN:

-5.52%

Fundamentals

Market Cap

FAT:

$49.13M

FGEN:

$31.08M

EPS

FAT:

-$11.60

FGEN:

-$1.53

PS Ratio

FAT:

0.08

FGEN:

1.05

PB Ratio

FAT:

12.81

FGEN:

53.83

Total Revenue (TTM)

FAT:

$440.69M

FGEN:

-$26.28M

Gross Profit (TTM)

FAT:

$114.50M

FGEN:

-$16.09M

EBITDA (TTM)

FAT:

-$22.27M

FGEN:

-$118.02M

Returns By Period


FAT

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

FGEN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FAT vs. FGEN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FAT
The Risk-Adjusted Performance Rank of FAT is 2626
Overall Rank
The Sharpe Ratio Rank of FAT is 2727
Sharpe Ratio Rank
The Sortino Ratio Rank of FAT is 2929
Sortino Ratio Rank
The Omega Ratio Rank of FAT is 2727
Omega Ratio Rank
The Calmar Ratio Rank of FAT is 2222
Calmar Ratio Rank
The Martin Ratio Rank of FAT is 2626
Martin Ratio Rank

FGEN
The Risk-Adjusted Performance Rank of FGEN is 1515
Overall Rank
The Sharpe Ratio Rank of FGEN is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of FGEN is 1616
Sortino Ratio Rank
The Omega Ratio Rank of FGEN is 1717
Omega Ratio Rank
The Calmar Ratio Rank of FGEN is 66
Calmar Ratio Rank
The Martin Ratio Rank of FGEN is 1616
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FAT vs. FGEN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for FAT Brands Inc. (FAT) and FibroGen, Inc. (FGEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

FAT vs. FGEN - Dividend Comparison

Neither FAT nor FGEN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

FAT vs. FGEN - Drawdown Comparison

The maximum FAT drawdown since its inception was -4.51%, smaller than the maximum FGEN drawdown of -8.46%. Use the drawdown chart below to compare losses from any high point for FAT and FGEN. For additional features, visit the drawdowns tool.


Loading data...

Volatility

FAT vs. FGEN - Volatility Comparison


Loading data...

Financials

FAT vs. FGEN - Financials Comparison

This section allows you to compare key financial metrics between FAT Brands Inc. and FibroGen, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-100.00M-50.00M0.0050.00M100.00M150.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
145.28M
-123.26M
(FAT) Total Revenue
(FGEN) Total Revenue
Values in USD except per share items

FAT vs. FGEN - Profitability Comparison

The chart below illustrates the profitability comparison between FAT Brands Inc. and FibroGen, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
25.0%
83.2%
(FAT) Gross Margin
(FGEN) Gross Margin
FAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, FAT Brands Inc. reported a gross profit of 36.28M and revenue of 145.28M. Therefore, the gross margin over that period was 25.0%.

FGEN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, FibroGen, Inc. reported a gross profit of -102.59M and revenue of -123.26M. Therefore, the gross margin over that period was 83.2%.

FAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, FAT Brands Inc. reported an operating income of -39.30M and revenue of 145.28M, resulting in an operating margin of -27.1%.

FGEN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, FibroGen, Inc. reported an operating income of -91.66M and revenue of -123.26M, resulting in an operating margin of 74.4%.

FAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, FAT Brands Inc. reported a net income of -67.42M and revenue of 145.28M, resulting in a net margin of -46.4%.

FGEN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, FibroGen, Inc. reported a net income of 17.98M and revenue of -123.26M, resulting in a net margin of -14.6%.